Both in R&D — Physical & Biological Sciences
bioAffinity Technologies vs Charles River Laboratories International
Over the past year BIAF returned −90.9% and CRL returned +97.4%; their daily moves had a correlation of 0.07.
BIAF −90.9% CRL +97.4%Growth of $1, one year, split-adjusted
| Metric | BIAF | CRL |
|---|---|---|
| Price | $3.15 | $353.12 |
| Market cap | $1.9M | $16.86B |
| Today | +5.35% | +4.31% |
| 1 month | −49.1% | +13.6% |
| 6 months | −89.6% | +90.5% |
| Year to date | −82.2% | +77.0% |
| 1 year | −91.4% | +96.1% |
| Revenue growth (YoY) | +19.0% | −2.7% |
| Gross margin | 100.0% | 36.2% |
| Net margin | −222.8% | −0.1% |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 4.2× |
| Net cash | $1.8M | -$2.43B |
| Dividend yield | — | — |
| Volatility (60d) | 825.9% | 41.6% |
| Short % of float | 11.4% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).